Skip to main
RLMD
RLMD logo

RLMD Market Capitalization Overview

Market Cap: $91.95M as of Nov 4, 2025

$91.95M
Past Month+$14.94M (19.40%)
As of Nov 4, 2025, RLMD has a market capitalization of $91.95M. Over the past 30 days, its market cap has increased by 1.85%, while in the last 12 months, it has increased by 485.96%.

Market capitalization represents the total value of Relmada Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

RLMD Market Cap Formula = Stock Price * Shares Outstanding

The market cap of RLMD helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RLMD Market Cap History

DateMarket CapChange
Nov 3, 2025$73.03M+1.85%
Oct 1, 2025$71.70M+52.11%
Sep 2, 2025$47.14M+140.52%
Aug 1, 2025$19.60M-4.17%
Jul 1, 2025$20.45M-13.04%
Jun 2, 2025$23.52M+102.60%
May 1, 2025$11.61M+27.81%
Apr 1, 2025$9.09M+18.02%
Mar 3, 2025$7.70M-24.98%
Feb 3, 2025$10.26M-24.48%
Jan 2, 2025$13.59M-86.32%

RLMD End of Year Market Cap History

DateMarket CapChange
2025$91.95M+485.96%
2024$15.70M-87.41%
2023$124.62M+18.62%
2022$105.05M-73.40%
2021$394.97M-24.17%
2020$520.87M

FAQs About Relmada Therapeutics Inc (RLMD) Market Cap

As of Nov 4, 2025, the market capitalization of RLMD is $91.95M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Relmada Therapeutics Inc’s market capitalization has increased by 19.40%, changing from $77.01M to $91.95M as of Nov 4, 2025.

In the last 3 months, Relmada Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Relmada Therapeutics Inc’s market capitalization decreased from $124.62M in January to $15.70M in December, reflecting a -87.41% change.

In the past five years, RLMD has had a compound annual growth rate (CAGR) of -50.37% in market capitalization. This means its market cap has shrunk at an average rate of -50.37% per year.

Relmada Therapeutics Inc (RLMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.